Scinai Immunotherapeutics (SCNI) Other Non-Current Assets (2015 - 2025)
Scinai Immunotherapeutics (SCNI) reported Other Non-Current Assets of $150000.0 for Q4 2025, up 14.5% on a YoY basis from $131000.0 in Q4 2024, and up 14.5% sequentially from $131000.0 in Q4 2024.
Scinai Immunotherapeutics (SCNI) Other Non-Current Assets (2015 - 2025) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 11 years of Other Non-Current Assets data on file, last reported at $150000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 14.5% year-over-year to $150000.0; the trailing twelve-month figure through Dec 2025 stood at $150000.0 (up 14.5% YoY), and the FY2025 full-year result was $150000.0, up 14.5% from the prior year.
- Other Non-Current Assets rose to $150000.0 in Q4 2025, from $131000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $437.0 million in Q2 2021 to a low of $127000.0 in Q1 2023.
- A 5-year average of $72.9 million and a median of $140000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 99.97% in 2021 and rose 14.5% in 2025, its largest moves.
- Tracing SCNI's Other Non-Current Assets over 5 years: stood at $143000.0 in 2021, then declined by 2.1% to $140000.0 in 2022, then changed by 0.0% to $140000.0 in 2023, then declined by 6.43% to $131000.0 in 2024, then rose by 14.5% to $150000.0 in 2025.
- Business Quant data shows SCNI's Other Non-Current Assets at $150000.0 in Q4 2025, $131000.0 in Q4 2024, and $140000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 139,000.00 |
| Mar 31, 2022 | 140,000.00 |
| Dec 31, 2021 | 143,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 437.00 Mn |
| Mar 31, 2021 | 436.00 Mn |
| Dec 31, 2020 | 473.00 Mn |
| Sep 30, 2020 | 259,000.00 |
| Jun 30, 2020 | 891.00 Mn |
| Mar 31, 2020 | 899.00 Mn |
| Dec 31, 2019 | 148,000.00 |
| Sep 30, 2019 | 146,000.00 |
| Jun 30, 2019 | 143,000.00 |
| Mar 31, 2019 | 196,000.00 |